Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: systematic analysis from the global burden of disease study 2019

By sjmartinez • June 29, 2024

Danpanichkul P, Suparan K, Dutta P, Kaeosri C, Sukphutanan B, Pang Y, Kulthamrongsri N, Jaisa-Aad M, Ng CH, Teng M, Nakano M, Morishita A, Alkhouri N, Yang JD, Chen VL, Kim D, Fallon MB, Diaz LA, Arab JP, Mantzoros CS, Noureddin M, Lazarus JV, Wijarnpreecha K. Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: systematic analysis from the global burden of disease study 2019. Metabolism. 2024 Jun 26:155958. doi: 10.1016/j.metabol.2024.155958. Epub ahead of print. PMID: 38942169.

Tags: Cedars Sinai DoM, Digestive Diseases, Disparity, Epidemiology, Liver disease, MASLD, Metabolic syndrome, NAFLD, non-alcoholic fatty liver disease

Opportunistic Screening of Chronic Liver Disease with Deep-Learning-Enhanced Echocardiography

Sahashi Y, Vukadinovic M, Amrollahi F, Trivedi H, Rhee J, Chen J, Cheng S, Ouyang D, Kwan AC. Opportunistic Screening of Chronic Liver Disease with[...]

Inflammation and dimensions of fatigue in women with early stage breast cancer: A longitudinal examination

Bower JE, Radin A, Ganz PA, Irwin MR, Cole SW, Petersen L, Asher A, Hurvitz SA, Crespi CM. Inflammation and dimensions of fatigue in women[...]

Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment

Fava A, Wagner CA, Guthridge CJ, Macwana S, DeJager W, Munroe ME, Izmirly P, Belmont HM, Diamond B, Davidson A, Utz PJ, Weisman MH, Carlucci[...]